Advances in Diagnosis, Pathological Mechanisms, Clinical Impact, and Future Therapeutic Perspectives in Tay-Sachs Disease. [PDF]
González-Sánchez M +2 more
europepmc +1 more source
Clinical and biochemical abnormalities in a feline model of GM2 activator deficiency. [PDF]
Beecy SJ +9 more
europepmc +1 more source
B4Galnt1 Deficiency Reverses Severe Neurological Symptoms in a Mouse Model of Tay-Sachs Disease. [PDF]
Yanbul S +3 more
europepmc +1 more source
Clinical outcome assessments of disease burden and progression in late-onset GM2 gangliosidoses. [PDF]
Kissell J +10 more
europepmc +1 more source
Genetic Modeling of Lysosomal Storage Disorders (LSDs) in the Brain-Midgut Axis of <i>Drosophila melanogaster</i> During Aging. [PDF]
Markaki SP +5 more
europepmc +1 more source
Systematic Review of Patient Focused Drug Development Meeting Reports for Conditions Affecting Neurodevelopment. [PDF]
Farmer C +5 more
europepmc +1 more source
New multiplex LC-MS/MS method for lipid biomarker analysis of inherited neurodegenerative metabolic diseases. [PDF]
Sidorina A +6 more
europepmc +1 more source
Dual-vector rAAVrh8 gene therapy for GM2 gangliosidosis: a phase 1/2 trial. [PDF]
Eichler F +35 more
europepmc +1 more source
Intrathecal delivery of AAVrh10-mHexa combined with anti-inflammatory treatment reduces neuropathological markers and extends the lifespan of mice with early-onset Tay-Sachs disease. [PDF]
Can M, Ausseil J, Seyrantepe V.
europepmc +1 more source
Agrawal Disease (Megalencephalic Leukoencephalopathy with Subcortical Cysts): A Rare Neurological Case Report. [PDF]
Davra SV, Srivastava R, Rawat P.
europepmc +1 more source

